Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

Microgel Insulin Delivery System Mimics Beta-Cell Action

By BiotechDaily International staff writers
Posted on 31 Jul 2013
Diabetes researchers have developed a nanotech technique to transport insulin in the bloodstream and release or sequester the hormone in response to changes in blood sugar levels.

Investigators at the University of North Carolina (Chapel Hill, USA) and their colleagues at the Massachusetts Institute of Technology (Cambridge, USA) used a one-step electrospray procedure to fabricate monodisperse microgels consisting of a pH-responsive chitosan matrix, enzyme nanocapsules, and recombinant human insulin. Glucose-specific enzymes were covalently encapsulated into the nanocapsules to improve enzymatic stability by protecting from denaturation and immunogenicity as well as to minimize loss due to diffusion from the matrix.

The microgel system swelled and released insulin when subjected to hyperglycemic conditions, as a result of the enzymatic conversion of glucose into gluconic acid and protonation of the chitosan network. The microgels acted as a self-regulating valve system by secreting insulin at basal release rates under normoglycemic conditions and at higher rates under hyperglycemic conditions.

Results published in the July 8, 2013, online edition of the journal ACS Nano revealed that in a mouse model of type I diabetes microgel-facilitated insulin release caused a reduction of blood glucose levels that lasted for more than 48 hours.

“The chitosan itself can be absorbed by the body, so there are no long term health effects,” said first author Dr. Zhen Gu, assistant professor of biomedical engineering the University of North Carolina. “We wanted to mimic the function of healthy beta-cells, which produce insulin and control its release in a healthy body, but what we have found also holds promise for smart drug delivery targeting cancer or other diseases.”

Related Links:
University of North Carolina
Massachusetts Institute of Technology



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.